Merck Capital Ventures: A US-based investment firm specializing in early to late-stage internet, pharmaceutical, and healthcare businesses.
Merck’s authorized product distributors are listed alphabetically, and the list is kept up to date.
Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck, its subsidiaries or affiliates, except as noted.
Merck provides safety data sheet information as a service to customers and others seeking it.
Merck company fact sheet for media professionals.
The page provides an archive of Merck's company statements.
An observational study assessed time to insulin initiation and the proportion of patients initiating insulin among people with type 2 diabetes taking JANUVIA and metformin or a sulfonylurea combination.
Merck’s manufacturing images are available for noncommercial use, including news reporting and research. They may not be modified and must display the specified copyright notice.
Meet Merck board member Mary Ellen Coe.
Meet Merck board member Pamela J. Craig.
Meet Merck board member Paul B. Rothman, M.D.
Risa J. Lavizzo-Mourey, M.D., is a Merck board member.
Merck's U.S. headquarters, worldwide office, adverse event, investors, media, supplies and animal health contact information.
HTG Molecular Diagnostics sets terms for its IPO. Merck Capital Ventures is listed among its shareholders with a 19.5% pre-IPO stake.
Apr 2015 · FortuneNews article
HTG Molecular Diagnostics announces the initial closing of its Series E preferred stock offering. Existing investors participating in the offering include Merck Capital Ventures.
Feb 2014 · AZBioNews article
NanoImaging Services completed a financing round led by Merck Capital Ventures. The company plans to use the funding to expand its service laboratory.
Feb 2008 · Technology NetworksNews article
Aegis Analytical closes $3.5 million in equity financing led by Skyland Capital. Merck Capital Ventures and other prior investors also participate.
Nov 2005 · The Denver PostNews article